Literature DB >> 12141276

Prolactin secretion is not a core dimension of "atypicality".

Gerhard Gründer, Otto Benkert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12141276     DOI： 10.1007/s00213-002-1066-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  8 in total

1.  An atypical compound by any other name is still a.

Authors:  H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

2.  Neuroendocrine response to antipsychotics: effects of drug type and gender.

Authors:  G Gründer; H Wetzel; R Schlösser; I Anghelescu; A Hillert; K Lange; C Hiemke; O Benkert
Journal:  Biol Psychiatry       Date:  1999-01-01       Impact factor: 13.382

Review 3.  Atypical antipsychotics: are some more atypical than others?

Authors:  G Remington; S Kapur
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

4.  Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia: an evaluation using confirmatory factor analysis.

Authors:  M J Müller; H Wetzel; O Benkert
Journal:  Int Clin Psychopharmacol       Date:  2002-09       Impact factor: 1.659

5.  Treatment of negative symptoms in schizophrenia with amisulpride.

Authors:  P Boyer; Y Lecrubier; A J Puech; J Dewailly; F Aubin
Journal:  Br J Psychiatry       Date:  1995-01       Impact factor: 9.319

6.  Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group.

Authors:  H Wetzel; G Gründer; A Hillert; M Philipp; W F Gattaz; H Sauer; G Adler; J Schröder; W Rein; O Benkert
Journal:  Psychopharmacology (Berl)       Date:  1998-06       Impact factor: 4.530

7.  Effect of sulpiride in endogenous depression.

Authors:  O Benkert; F Holsboer
Journal:  Acta Psychiatr Scand Suppl       Date:  1984

8.  The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patients.

Authors:  G Gründer; H Wetzel; A Hillert; E Jochum; C Hiemke; O Benkert
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530
  8 in total
  1 in total

Review 1.  The 'atypicality' of antipsychotics: a concept re-examined and re-defined.

Authors:  Gerhard Gründer; Hanns Hippius; Arvid Carlsson
Journal:  Nat Rev Drug Discov       Date:  2009-02-13       Impact factor: 84.694
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.